Ipsen - 2021 SM - Results and replay - 31 May 2021
Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Newsroom arrow down
      < Back
    • Newsroom
    • Press Releases
    • Media Updates
    • Media Resources
    • Media Contacts
    • Subscribe
  • Investors arrow down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Annual Reports & Regulated Information
    • Investor Events & Financial Calendar
    • Shareholder Information
    • Subscribe
    • Ratings & Bonds
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
    • Job Search
  • Contacts arrow down
      < Back
    • Contacts
    • Contacts
    • Our Locations
    • Report Side Effects
    • Subscribe
  • Press shift tab to select search category

    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  •  Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
    • UAE & Gulf
    • Saudi Arabia
  • Home
  • Company
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Expertise
      < Back
    • Expertise
    • Oncology
    • Rare Disease
    • Neuroscience
    • Medicines
  • Science
      < Back
    • Science
    • Science
        < Back
      • Science
      • Oncology
      • Rare Disease
      • Neuroscience
    • Profiles
    • Partnering
        < Back
      • Partnering
      • Therapeutic focus
      • Meet the team
    • Clinical Trials
        < Back
      • Clinical Trials
      • Lay Summaries
      • Find Clinical Trials
    • Pipeline
  • Sustainability
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • Patients
    • People
    • Governance
    • Our Standards
  • Patients
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Collaborate with us
  • Stories
  1. Home
  2. Press Releases
  3. Shareholders Meeting press releases

Ipsen – 2021 SM – Results and replay – 31 May 2021

Post navigation

Previous
Next

Ipsen – 2021 SM – Results and replay – 31 May 2021

Ipsen – 2021 SM – Results and replay – 31 May 2021

- 09 June 2021 - 0 mins read

Post navigation

Previous
Next
Related Documents
  • Ipsen 2021 SM Results 31 May 2021 1   Download  (165 KB)
  • Replay SM VA 2021   Download  (107 KB)
Related links
  • Watch the replay    Watch the replay Open in new tab

Related Press Releases

21 May 2025

Ipsen S.A. – Annual General Meeting held on 21 May 2025

30 April 2025

Ipsen S.A. – Formalities for making available and consulting preparatory documents to the 2025 Annual General Meeting

28 May 2024

Annual General Meeting of Ipsen S.A. held on 28 May 2024

01 June 2023

Combined Shareholders’ Meeting of Ipsen S.A. held on 31 May 2023

31 May 2023

Description of the regulatory framework of the share repurchase program to be approved at the Combined Shareholders’ Meeting on 31...

03 June 2022

IPSEN – 2022 SM – Voting results and replay

05 May 2021

Combined Shareholders’ Meeting of 27 May 2021

07 May 2020

Combined Shareholders’ Meeting of 29 May 2020

17 April 2019

Combined Shareholders’ Meeting of 28 May 2019

IPN price

€167.50

 €2.40 (1.45%)

  • Media Resources
  • Annual Report
  • Contacts
  • Our Locations

Ipsen logo
LinkedIn Instagram Facebook Youtube
  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy

© Ipsen Pharma. All rights reserved - 2026

You are now leaving the Ipsen group global website. To continue, please click on Continue?

Continue